Lineagen is a provider of diagnostic and healthcare services focused on complex diseases for which individuals genetic profiles contribute strongly to their susceptibility. Lineagen is committed to improving outcomes for those affected by autism and other complex diseases, for which effective early diagnosis and intervention can have a significant positive impact. The Company's comprehensive genetic testing and support/counseling service are initially designed to enable early evaluation of children at risk for disorders of childhood development, including autism spectrum disorders (ASDs). Founded in 2002, Lineagen's commercial strategy represents the culmination of significant proprietary research into genetic causes and diagnostic pathways of key complex diseases, including autism, MS and COPD. One of the company's core research competitive advantages is its access through the University of Utah to the Utah Population Database, an unmatched biomarker discovery research platform that has been used to help the University identify more disease-related genes than any other institution in the world.

Show more
Type
Private
HQ
Salt Lake City, US
Founded
2002
Size (employees)
102 (est)
Lineagen was founded in 2002 and is headquartered in Salt Lake City, US
Report incorrect company information

Key People/Management at Lineagen

M.S. Rena Vanzo

M.S. Rena Vanzo

Vice President, Clinical Genetics
E. Wassman

E. Wassman

Chief Medical Adviser
Michael Paul

Michael Paul

CEO, President, Co-Founder
Andy Peiffer

Andy Peiffer

Director, Pediatric Genetics
Stephen Prescott

Stephen Prescott

Independent Director, Co-Founder

Lineagen Office Locations

Lineagen has an office in Salt Lake City
Salt Lake City, US (HQ)
2677 E Parleys Way
Show all (1)
Report incorrect company information

Lineagen Financials and Metrics

Summary Metrics

Lineagen's latest funding round in January 2015 was reported to be $12.7 m. In total, Lineagen has raised $48.8 m
Report incorrect company information